CD36 and metabolic dysfunction-associated steatohepatitis: Inhibition of CD36 palmitoylation reduces its hydrophobicity and accessibility to the plasma membrane and causes a decrease in the binding and uptake of long-chain FAs, such as palmitate, in hepatic cells, which protects mice from nonalcoholic steatohepatitis and fibrosis (19).